abs51.txt	background		crohn's	disease	(cd)	is	highly	heterogeneous	due	in	large	part	tovariability	cellular	processes	that	underlie	the	natural	history	of	cd	thereby	confounding	effective	therapy	there	a	critical	need	to	advanceunderstanding	mechanisms	drive	heterogeneity	methods	we	performed	small	rna	sequencing	adult	colon	tissue	from	and	nibdcontrols	colonic	epithelial	cells	immune	were	isolated	colonictissues	microrna-31	(mir-31)	expression	was	measured	mir-31	wasmeasured	colonoid	cultures	generated	controls	patients	with	weperformed	rna-sequencing	formalin-fixed	paraffin-embedded	andileum	biopsies	treatment-naive	pediatric	andcollected	data	on	features	outcomes	results	microrna	profiling	revealed	2distinct	molecular	subtypes	each	different	clinical	associations	notably	found	driver	these	2	further	particularly	pronounced	colonoidsrevealed	differences	are	preserved	this	ex	vivo	system	low	levels	at	time	surgerywere	associated	worse	outcome	as	by	for	an	endileostomy	recurrence	neoterminal	ileum	pediatricpatients	lower	diagnosis	withfuture	development	fibrostenotic	ileal	requiring	surgeryconclusions	thesefindings	represent	important	step	forward	designing	more	clinicaltrials	developing	personalized	therapies	funding	work	supported	ccf	career	award	(szs)	r01-es024983	niehs	(szs	tsf)	1r01dk104828-01a1	niddk	andtsf)	p01-dk094779-01a1	p30-dk034987	1-16-ace-47	ada	pathway	(ps)	unc	nutrition	obesity	research	center	pilot	&feasibility	grant	p30dk056350	pro-kiids	network	ps)	cgibdt32	training	(jbb)	t32	(5t32gm007092-42)	fromnigms	(mh)	share	helmsley	trust	translationalpathology	laboratory	grants	national	cancerinstitute	(3p30ca016086)	university	cancer	fund	(ucrf)
